Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are associated with disease-initiating stem cells that are not eliminated by conventional therapies. Transcriptomic analysis of stem and progenitor populations in MDS and AML demonstrated overexpression of STAT3 that was validated in a...
Váldodahkkit: | Shastri, A, Choudhary, G, Teixeira, M, Gordon-Mitchell, S, Ramachandra, N, Bernard, L, Bhattacharyya, S, Lopez, R, Pradhan, K, Giricz, O, Ravipati, G, Wong, L, Cole, S, Bhagat, T, Feld, J, Dhar, Y, Bartenstein, M, Thiruthuvanathan, V, Wickrema, A, Ye, B, Frank, D, Pellagatti, A, Boultwood, J, Zhou, T, Kim, Y, Macleod, A, Epling-Burnette, P, Ye, M, McCoon, P, Woessner, R, Steidl, U, Will, B, Verma, A |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
American Society for Clinical Investigation
2018
|
Geahča maid
-
Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome
Dahkki: Bhagat, T, et al.
Almmustuhtton: (2017) -
Gene expression and risk of leukemic transformation in myelodysplasia
Dahkki: Shiozawa, Y, et al.
Almmustuhtton: (2017) -
Single cell analysis of normal and leukemic hematopoiesis
Dahkki: Povinelli, B, et al.
Almmustuhtton: (2017) -
The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission
Dahkki: Jeanpierre, S, et al.
Almmustuhtton: (2020) -
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
Dahkki: Will, B, et al.
Almmustuhtton: (2012)